Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference
- 24 June 2013
- journal article
- research article
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 68 (4) , 251-258
Abstract
Background. Psychosis is associated with excess cardiovascular morbidity and mortality. Aims. To determine the prevalence of cardiovascular risk factors in patients with psychotic disorders compared with the population. Methods. 731 consecutive patients with psychosis recruited from psychiatric outpatient clinics in Stockholm County, Sweden, were compared with 5580 individuals from a population study performed in the same area. The main outcome measures were waist circumference, body mass index (BMI) and fasting glucose. Results. Mean waist circumference in patients vs. controls was for males 106 and 94 cm, respectively, and for females 97 and 85 cm, respectively (P < 0.001); mean fasting glucose in patients vs. controls was for males 5.8 and 5.2 mmol/l, respectively, and for females 5.6 and 4.8 mmol/l, respectively (P < 0.001). Comparisons were controlled for differences in age and family history of diabetes. Increased waist circumference was more common in psychotic patients compared with controls (OR = 3.99; 95% CI 3.09–5.15), controlling for fasting insulin, differences in gender, blood pressure, fasting glucose, family history of diabetes, age and tobacco use. Increased fasting blood glucose was also more common in psychotic patients (OR = 2.41; 95% CI 1.84–3.14) controlling for the same factors with the exception of fasting glucose and with the addition of increased waist circumference. Conclusion. Our study shows that the psychosis illness per se can be considered as a cardiovascular risk factor, independent of the traditional risk factors such as age and smoking.Keywords
This publication has 36 references indexed in Scilit:
- Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting InjectionSchizophrenia Research and Treatment, 2012
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005Circulation, 2009
- Factors determining normalization of glucose intolerance in middle‐aged Swedish men and women: a 8–10‐year follow‐upDiabetic Medicine, 2009
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- Psychological distress and risk of pre‐diabetes and Type 2 diabetes in a prospective study of Swedish middle‐aged men and womenDiabetic Medicine, 2008
- A Systematic Review of Mortality in SchizophreniaArchives of General Psychiatry, 2007
- Extent and Management of Cardiovascular Risk Factors in Patients With Type 2 Diabetes and Serious Mental IllnessJournal of Nervous & Mental Disease, 2006
- Second-Generation (Atypical) Antipsychotics and Metabolic EffectsCNS Drugs, 2005
- Physical consequences of schizophrenia and its treatmentLife Sciences, 2002